Abstract:Background: Energy metabolism deficiency is part of the acute kidney injury (AKI) pathophysiology. Recent studies highlighted the role of nicotinamide adenine dinucleotide (NAD) production in the pathogenesis of AKI. NAD is an electron carrier for mitochondria and a cofactor for cytoplasmic redox reactions. Its production is decreased during AKI following a decrease of the expression of PGC1 α (Peroxisome proliferator activated receptor gamma co-activator-1-α ) and an alteration of its de novo synthesis pathway: with a reduction in the expression of the Quinolinate PhosphoRibosylTransferase (QPRT). The modulation of this de novo pathway has been studied mainly in the acute phase immediately after AKI. However, its correlation with the severity of the ischemic insult and its evolution during the transition from AKI to CKD have not been described yet. Methods: Renal ischemia-reperfusion was performed in C57Bl6/J male mice after nephrectomy of the contralateral kidney. For the ’severity’ study, a 5-30 minutes ischemia was performed. Renal function was assessed 24h after ischemia. For the ‘AKI to CKD’ study, renal ischemia was performed during 10 minutes. Mice were sacrificed 1, 2, 3, 6 and 28 days after ischemia. PGC1 α and QPRT mRNA expression was measured by RT-qPCR. Results: We induced AKI in mice by unilateral ischemia reperfusion injury of increasing time to induce several degrees of AKI severity. PGC1 α and QPRT mRNA expression decreased progressively with ischemia severity until reaching a plateau at 15 minutes of ischemia for PGC1 α , like plasma creatinine and urea, whereas QPRT decrease is linear until 30 min of ischemia. PGC1 α mRNA decrease is also inversely correlated to kidney dysfunction (p<0.001). A 10-minute ischemia led to the development of Chronic Kidney Disease (CKD), as evidenced by an incomplete recovery of the kidney function at 28 days. QPRT and PGC1 α mRNA expression showed a progressive but incomplete recovery during the transition from AKI to CKD compared to sham mice. Conclusions: In addition to confirming the decrease of PGC α and QPRT mRNA expression during AKI, we show that it is correlated to the severity of the ischemic AKI. Furthermore, we describe the recovery during renal repair and transition to CKD.

Early involvement of oxidative stress in the progression of chronic kidney disease induced by an acute kidney injury episode (667.6)

Cell Profiling of Acute Kidney Injury to Chronic Kidney Disease Reveals Novel Oxidative Stress Characteristics in the Failed Repair of Proximal Tubule Cells

Oxidative Stress in Animal Models of Acute and Chronic Renal Failure

Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease

Longitudinal biomarkers and kidney disease progression after acute kidney injury

ADAMTS13 Inhibits Oxidative Stress and Ameliorates Progressive Chronic Kidney Disease Following Ischaemia/reperfusion Injury.

Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne’s Thread

Acute kidney disease in mice is associated with early cardiovascular dysfunction

Unraveling the Pathophysiological Mechanisms of the Progression from Acute Kidney Injury to Acute Kidney Disease to Chronic Kidney Disease

GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition

Oxidative stress in patients with chronic kidney diseases and the related factors

Oxidative Stress in Patients with Advanced CKD and Renal Replacement Therapy: The Key Role of Peripheral Blood Leukocytes

Kinetics of the De Novo NAD/NADH Pathway from AKI to CKD

Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1 β and IL-18 and Arrests CKD

Earlier Renal Fibrosis Aggravates Acute Kidney Injury Induced by Ischemia Reperfusion in Mice

Novel predictive biomarkers for acute injury superimposed on chronic kidney disease

Chronic Kidney Disease Induced Intestinal Mucosal Barrier Damage Associated with Intestinal Oxidative Stress Injury

Oxidative stress initiates hemodynamic change in CKD-induced heart disease

Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury

Oxidative stress and the role of redox signalling in chronic kidney disease

Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease